Published in N Engl J Med on May 11, 1995
Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ (2000) 35.06
In patients with type 1 diabetes and new-onset microalbuminuria the development of advanced chronic kidney disease may not require progression to proteinuria. Kidney Int (2010) 2.82
Circulating TNF receptors 1 and 2 predict ESRD in type 2 diabetes. J Am Soc Nephrol (2012) 2.75
Risk for ESRD in type 1 diabetes remains high despite renoprotection. J Am Soc Nephrol (2011) 2.50
Interaction between poor glycemic control and 9p21 locus on risk of coronary artery disease in type 2 diabetes. JAMA (2008) 1.88
High-normal serum uric acid is associated with impaired glomerular filtration rate in nonproteinuric patients with type 1 diabetes. Clin J Am Soc Nephrol (2008) 1.74
Regression of microalbuminuria in type 1 diabetes is associated with lower levels of urinary tubular injury biomarkers, kidney injury molecule-1, and N-acetyl-β-D-glucosaminidase. Kidney Int (2010) 1.67
Serum concentrations of markers of TNFalpha and Fas-mediated pathways and renal function in nonproteinuric patients with type 1 diabetes. Clin J Am Soc Nephrol (2008) 1.62
Urinary peptidome may predict renal function decline in type 1 diabetes and microalbuminuria. J Am Soc Nephrol (2009) 1.57
Association of urinary inflammatory markers and renal decline in microalbuminuric type 1 diabetics. J Am Soc Nephrol (2008) 1.44
Role of podocyte B7-1 in diabetic nephropathy. J Am Soc Nephrol (2014) 1.33
Screening to prevent renal failure in insulin dependent diabetic patients: an economic evaluation. BMJ (1995) 1.22
Revisiting the oral glucose tolerance test criterion for the diagnosis of diabetes. J Gen Intern Med (2000) 1.19
Prevalence of microalbuminuria in type 2 diabetes mellitus at a diabetes centre in southern India. Postgrad Med J (2001) 1.14
Albuminuria and peripheral arterial disease: results from the multi-ethnic study of atherosclerosis (MESA). Atherosclerosis (2008) 1.10
Renal hyperfiltration and the development of microalbuminuria in type 1 diabetes. Diabetes Care (2009) 1.03
Diabetic nephropathy: diagnosis and treatment. Nat Rev Endocrinol (2013) 0.98
Progressive renal decline: the new paradigm of diabetic nephropathy in type 1 diabetes. Diabetes Care (2015) 0.97
Microalbuminuria in diabetes mellitus. CMAJ (2002) 0.97
Diagnosing diabetes with glucose criteria: worshiping a false God. Diabetes Care (2011) 0.96
High risk of ESRD in type 1 diabetes: new strategies are needed to retard progressive renal function decline. Semin Nephrol (2012) 0.93
Diabetic nephropathy in children and adolescents. Pediatr Nephrol (2007) 0.92
Serum levels of advanced glycation endproducts and other markers of protein damage in early diabetic nephropathy in type 1 diabetes. PLoS One (2012) 0.91
Patterns of Estimated Glomerular Filtration Rate Decline Leading to End-Stage Renal Disease in Type 1 Diabetes. Diabetes Care (2016) 0.89
Systematic review and meta-analysis of the effectiveness of continuous glucose monitoring (CGM) on glucose control in diabetes. Diabetol Metab Syndr (2013) 0.89
Improved glycemic control and risk of ESRD in patients with type 1 diabetes and proteinuria. J Am Soc Nephrol (2014) 0.89
Identification and prediction of group-based glycemic control trajectories during the transition to adolescence. Health Psychol (2013) 0.88
Cardiac autonomic neuropathy and early progressive renal decline in patients with nonmacroalbuminuric type 1 diabetes. Clin J Am Soc Nephrol (2015) 0.84
Glycosylated hemoglobin and the risk of microalbuminuria in insulin-dependent diabetes mellitus. EURODIAB IDDM Complications Study Group. N Engl J Med (1995) 0.83
Prevalence of microalbuminuria and its risk factors in type 2 diabetic patients. Indian J Nephrol (2008) 0.82
Genetic Predictors of Cardiovascular Mortality During Intensive Glycemic Control in Type 2 Diabetes: Findings From the ACCORD Clinical Trial. Diabetes Care (2016) 0.82
Improvement and emergence of insulin restriction in women with type 1 diabetes. Diabetes Care (2011) 0.82
Risk of ESRD and all cause mortality in type 2 diabetes according to circulating levels of FGF-23 and TNFR1. PLoS One (2013) 0.81
Genetic variation in the matrix metalloproteinase genes and diabetic nephropathy in type 1 diabetes. Mol Genet Metab (2011) 0.80
Relationship among psychopathological dimensions, coping mechanisms, and glycemic control in a Croatian sample of adolescents with diabetes mellitus type 1. Eur Child Adolesc Psychiatry (2009) 0.78
Pro's and con's of the early use of insulin in the management of type 2 diabetes: a clinical evaluation. Curr Opin Endocrinol Diabetes Obes (2009) 0.77
Effective antihypertensive strategies for high-risk patients with diabetic nephropathy. J Investig Med (2010) 0.76
Association of high normal HbA1c and TSH levels with the risk of CHD: a 10-year cohort study and SVM analysis. Sci Rep (2017) 0.75
Diagnostic criteria for diabetes revisited: making use of combined criteria. BMC Endocr Disord (2002) 0.75
No need for the needle (at first). Diabetes Care (2008) 0.75
Glycated haemoglobin A1c is associated with low-grade albuminuria in Chinese adults. BMJ Open (2015) 0.75
Fast renal decline to end-stage renal disease: an unrecognized feature of nephropathy in diabetes. Kidney Int (2017) 0.75
A glycemic threshold for diabetic complications? N Engl J Med (1995) 0.75
Growth factors and diabetic nephropathy: kidney structure and therapeutic interventions. Diabetologia (1997) 0.75
Experimental annotation of the human genome using microarray technology. Nature (2001) 10.39
Role of glucose and insulin resistance in development of type 2 diabetes mellitus: results of a 25-year follow-up study. Lancet (1992) 6.28
Magnitude and determinants of coronary artery disease in juvenile-onset, insulin-dependent diabetes mellitus. Am J Cardiol (1987) 4.27
The changing natural history of nephropathy in type I diabetes. Am J Med (1985) 3.50
The precautionary principle in environmental science. Environ Health Perspect (2001) 3.47
Predictors of glycemic control and short-term adverse outcomes in youth with type 1 diabetes. J Pediatr (2001) 3.28
Precancerous changes in the cervix and risk of subsequent preterm birth. BJOG (2006) 3.25
An office-based intervention to maintain parent-adolescent teamwork in diabetes management. Impact on parent involvement, family conflict, and subsequent glycemic control. Diabetes Care (1999) 2.97
Mutations in NEUROD1 are associated with the development of type 2 diabetes mellitus. Nat Genet (1999) 2.80
Modern methods of searching the medical literature. Med J Aust (1992) 2.58
Familial factors determine the development of diabetic nephropathy in patients with IDDM. Diabetologia (1996) 2.53
Human alpha-galactosidase A: nucleotide sequence of a cDNA clone encoding the mature enzyme. Proc Natl Acad Sci U S A (1986) 2.51
2004 consensus statements on the management of ovarian cancer: final document of the 3rd International Gynecologic Cancer Intergroup Ovarian Cancer Consensus Conference (GCIG OCCC 2004). Ann Oncol (2005) 2.33
Outcomes of screening to prevent cancer: analysis of cumulative incidence of cervical abnormality and modelling of cases and deaths prevented. BMJ (2003) 2.30
Differences in risk of insulin-dependent diabetes in offspring of diabetic mothers and diabetic fathers. N Engl J Med (1984) 2.26
Analysis of xylem formation in pine by cDNA sequencing. Proc Natl Acad Sci U S A (1998) 2.21
The incidence of breast cancer in the General Practice Research Database compared with national cancer registration data. Br J Cancer (2000) 2.17
European Code Against Cancer and scientific justification: third version (2003). Ann Oncol (2003) 2.17
The PATHWAYS church-based weight loss program for urban African-American women at risk for diabetes. Diabetes Care (1997) 2.16
Excess mortality associated with diuretic therapy in diabetes mellitus. Arch Intern Med (1991) 1.99
Socioeconomic inequalities in cancer survival in England and Wales. Cancer (2001) 1.83
Risk of mortality, cancer incidence, and stroke in a population potentially exposed to cadmium. Occup Environ Med (2000) 1.77
Estrogen excretion patterns and plasma levels in vegetarian and omnivorous women. N Engl J Med (1982) 1.77
Magnitude of end-stage renal disease in IDDM: a 35 year follow-up study. Kidney Int (1996) 1.63
Trends in the incidence of primary liver and biliary tract cancers in England and Wales 1971-2001. Br J Cancer (2006) 1.58
Epidemiologic approach to the etiology of type I diabetes mellitus and its complications. N Engl J Med (1987) 1.58
Cancer prevalence in the UK: results from the EUROPREVAL study. Ann Oncol (2003) 1.57
Use of an automated device for alternative site blood glucose monitoring. Diabetes Care (2001) 1.57
Remission induction comparing infliximab and high-dose intravenous steroid, followed by treat-to-target: a double-blind, randomised, controlled trial in new-onset, treatment-naive, rheumatoid arthritis (the IDEA study). Ann Rheum Dis (2013) 1.53
A randomised controlled trial of etanercept and methotrexate to induce remission in early inflammatory arthritis: the EMPIRE trial. Ann Rheum Dis (2014) 1.52
Shortened telomere length in white blood cells of patients with IDDM. Diabetes (1998) 1.52
The inferior hypogastric plexus: a different view. J Obstet Gynaecol (2007) 1.49
Risk of proliferative diabetic retinopathy in juvenile-onset type I diabetes: a 40-yr follow-up study. Diabetes Care (1986) 1.48
Risk of diabetes in siblings of index cases with Type 2 diabetes: implications for genetic studies. Diabet Med (2002) 1.47
The role of oral contraceptive agents in cerebral arterial occlusion. Neurology (1969) 1.47
Validation and reproducibility of ultrasonography in the detection of synovitis in the knee: a comparison with arthroscopy and clinical examination. Arthritis Rheum (2004) 1.45
Phase I study of the heat shock protein 90 inhibitor alvespimycin (KOS-1022, 17-DMAG) administered intravenously twice weekly to patients with acute myeloid leukemia. Leukemia (2010) 1.41
Cardiac carcinoid: tricuspid delayed hyperenhancement on cardiac 64-slice multidetector CT and magnetic resonance imaging. Ir J Med Sci (2009) 1.40
The paradox of the low-renin state in diabetic nephropathy. J Am Soc Nephrol (1999) 1.38
Predisposition to hypertension and susceptibility to renal disease in insulin-dependent diabetes mellitus. N Engl J Med (1988) 1.37
Assessing health impact assessment: multidisciplinary and international perspectives. J Epidemiol Community Health (2003) 1.37
Small cell of the ovary, hypercalcemic type -- analysis of combined experience and recommendation for management. A GCIG study. Gynecol Oncol (2006) 1.36
New susceptibility locus for NIDDM is localized to human chromosome 20q. Diabetes (1997) 1.35
A genome-wide linkage scan for genes controlling variation in urinary albumin excretion in type II diabetes. Kidney Int (2006) 1.34
Hypertension: the major risk factor in juvenile-onset insulin-dependent diabetics. Diabetes (1981) 1.33
Tubal sterilisation, hysterectomy and decreased risk of ovarian cancer. Survey of Women's Health Study Group. Int J Cancer (1997) 1.31
Downregulation of urokinase plasminogen activator receptor expression inhibits Erk signalling with concomitant suppression of invasiveness due to loss of uPAR-beta1 integrin complex in colon cancer cells. Br J Cancer (2003) 1.31
Survival from breast cancer among South Asian and non-South Asian women resident in South East England. Br J Cancer (2003) 1.30
Ultrasound-guided fetal blood transfusion for severe rhesus isoimmunization. Obstet Gynecol (1985) 1.29
Major susceptibility locus for nephropathy in type 1 diabetes on chromosome 3q: results of novel discordant sib-pair analysis. Diabetes (1998) 1.28
European health systems and cancer care. Ann Oncol (2003) 1.27
High-efficiency Agrobacterium-mediated transformation of Norway spruce (Picea abies) and loblolly pine (Pinus taeda). Plant Mol Biol (1999) 1.26
Glycosylated hemoglobin and the risk of retinopathy in insulin-dependent diabetes mellitus. N Engl J Med (1995) 1.25
Hypercholesterolemia--a determinant of renal function loss and deaths in IDDM patients with nephropathy. Kidney Int Suppl (1994) 1.22
Risk of advanced diabetic nephropathy in type 1 diabetes is associated with endothelial nitric oxide synthase gene polymorphism. Kidney Int (2000) 1.21
Foodborne Norwalk virus. Am J Epidemiol (1982) 1.19
Reproductive and other factors and risk of epithelial ovarian cancer: an Australian case-control study. Survey of Women's Health Study Group. Int J Cancer (1995) 1.18
Risk factors for progression of background retinopathy in long-standing IDDM. Diabetes (1989) 1.18
Estimated morbidity and mortality in adolescents and young adults diagnosed with Type 2 diabetes mellitus. Diabet Med (2012) 1.18
A nonlinear effect of hyperglycemia and current cigarette smoking are major determinants of the onset of microalbuminuria in type 1 diabetes. Diabetes (2001) 1.14
Ascites induces modulation of alpha6beta1 integrin and urokinase plasminogen activator receptor expression and associated functions in ovarian carcinoma. Br J Cancer (2005) 1.13
Genetic predisposition to diabetic nephropathy. Evidence for a role of the angiotensin I--converting enzyme gene. Diabetes (1994) 1.13
Further evidence for a susceptibility locus for type 2 diabetes on chromosome 20q13.1-q13.2. Diabetes (2000) 1.12
Fabry disease: isolation of a cDNA clone encoding human alpha-galactosidase A. Proc Natl Acad Sci U S A (1985) 1.11
Multiple factors in the prediction of risk of proliferative diabetic retinopathy. N Engl J Med (1985) 1.10
Evidence for prebudding arrest of ER export in animal cell mitosis and its role in generating Golgi partitioning intermediates. Traffic (2001) 1.10
Acute postchallenge hyperinsulinemia predicts weight gain: a prospective study. Diabetes (1997) 1.09
Trends in prostate cancer incidence, mortality and survival in England and Wales 1971-1998. BJU Int (2000) 1.09
Life expectancy and cancer survival in the EUROCARE-3 cancer registry areas. Ann Oncol (2003) 1.08
Eating style and eating behaviour in adolescents. Appetite (1992) 1.07
Effect of diet on excretion of estrogens in pre- and postmenopausal women. Cancer Res (1981) 1.07
Risk of early-onset proliferative retinopathy in IDDM is closely related to cardiovascular autonomic neuropathy. Diabetes (1992) 1.06
Evolving natural history of coronary artery disease in diabetes mellitus. Am J Med (1991) 1.05
Progression of microalbuminuria to proteinuria in type 1 diabetes: nonlinear relationship with hyperglycemia. Diabetes (2000) 1.05
Urinary albumin excretion in families with type 2 diabetes is heritable and genetically correlated to blood pressure. Kidney Int (2000) 1.04
Familial clustering of insulin sensitivity. Diabetes (1992) 1.04
Evidence of a novel type 2 diabetes locus 50 cM centromeric to NIDDM2 on chromosome 12q. Diabetes (1999) 1.01
Application of a low cost telemedicine link to the diagnosis of neonatal congenital heart defects by remote consultation. Heart (1999) 1.01
Impact of weight change and weight cycling on risk of different subtypes of endometrial cancer. Eur J Cancer (2013) 1.00
Effect of a lactobacilli preparation on traveler's diarrhea. A randomized, double blind clinical trial. Gastroenterology (1978) 0.99
Survival of breast cancer patients related to incidence risk factors. Int J Cancer (1972) 0.98
Strategies to improve the reporting of legal blindness in Massachusetts. Am J Public Health (1997) 0.98
Incidence of malignant disease by morphological type, in young persons aged 12-24 years in England, 1979-1997. Eur J Cancer (2003) 0.98
Support for studies in paediatric medicine is needed. BMJ (2000) 0.96
Bone loss in patients with active early rheumatoid arthritis: infliximab and methotrexate compared with methotrexate treatment alone. Explorative analysis from a 12-month randomised, double-blind, placebo-controlled study. Ann Rheum Dis (2009) 0.96
Type 2 diabetes locus on 12q15. Further mapping and mutation screening of two candidate genes. Diabetes (2001) 0.96
Does the use of tumour necrosis factor antagonist therapy in poor prognosis, undifferentiated arthritis prevent progression to rheumatoid arthritis? Ann Rheum Dis (2008) 0.96
Apolipoprotein E genotypes and risk of diabetic nephropathy. J Am Soc Nephrol (1996) 0.96
Pharmacokinetics of morphine infusion in premature neonates. Arch Dis Child (1993) 0.95
Phosphorylation of ribosomal protein S6 and a peptide analogue of S6 by a protease-activated kinase isolated from rat liver. FEBS Lett (1984) 0.95
Detection of genital human papillomavirus (HPV) DNA by PCR and other conventional hybridisation techniques in male partners of women with abnormal Papanicolaou smears. Genitourin Med (1992) 0.95
Elevated serum inhibin concentrations in postmenopausal women with ovarian tumors. N Engl J Med (1993) 0.94
Value of a low-cost telemedicine link in the remote echocardiographic diagnosis of congenital heart defects. J Telemed Telecare (1998) 0.94
Struma ovarii presenting as acute pseudo-Meigs syndrome with an elevated CA 125 level. Aust N Z J Obstet Gynaecol (1996) 0.93
Hypertension, orthostatic hypotension and the microvascular complications of diabetes. J Chronic Dis (1985) 0.93
Follicular non-Hodgkin lymphoma grades 3A and 3B have a similar outcome and appear incurable with anthracycline-based therapy. Ann Oncol (2010) 0.93
Phenotypic characteristics of early-onset autosomal-dominant type 2 diabetes unlinked to known maturity-onset diabetes of the young (MODY) genes. Diabetes Care (1999) 0.93